The medical community recognizes sex-related differences in pathophysiology and
cardiovascular disease outcomes (CVD), culminating with heart failure. In general, pre …

Sex differences in cardiovascular disease (CVD) are often recognized from experimental
and clinical studies examining the prevalence, manifestations, and response to therapies …

The limited endogenous regenerative capacity of the human heart renders cardiovascular
diseases a major health threat, thus motivating intense research on in vitro heart cell …

Recent evidence shows the cardiometabolic effects of estrogen administration in
postmenopausal women. Women have a cardiometabolic advantage during their …

Hypovitaminosis D is involved in various inflammatory, infectious and autoimmune diseases
such as rheumatoid arthritis and multiple sclerosis. Moreover, the active form of vitamin D …

The negative cardiovascular effects of polycystic ovary syndrome (PCOS) and vitamin D
deficiency (VDD) have been discussed previously; however, the sex differences between …

Objective: Previous studies suggested that ethnic differences, sex and obesity could modify
the relationship between 25-hydroxyvitamin D [25 (OH) D], glycometabolic markers and/or …

Background Sex-related differences in cardiovascular disease are now gaining much more
attention and their importance is increasingly being recognized, but little is known about the …

Background Previous studies on the liner associations between serum 25-hydroxyvitamin D
[25 (OH) D] levels and lipid profiles revealed ambiguous findings. The current study …

Although cardiovascular diseases (CVD) are the leading cause of non-communicable
diseases-dependent death worldwide, their effects are still largely underestimated in women …